Full Press Release Details
MATERIAL CHANGE REPORT
Item 1 Name and Address of Company
Aurora Cannabis Inc. ("Aurora"
Item 2 Date of Material Change
A press release describing the material change was
disseminated by Aurora on February 8, 2024 through Cision PR Newswire and can be found on SEDAR+ at www.sedarplus.ca.
Item 4 Summary of Material Change
A wholly-owned subsidiary ("Aurora Sub")
acquired the remaining approximately 90% equity interest that Aurora did not previously own of Indica Industries Pty Ltd ("MedReleaf
Australia"), a leading distributor of medical cannabis products, for an enterprise value of AUD$50 million, subject to customary
adjustments. Aurora paid AUD$9.45 million in cash with the balance of the purchase price satisfied by the issuance of common shares of
Aurora (the "Aurora Shares").
Item 5 Full Description of Material Change
Description of Material Change
On February 7, 2024, Aurora, through Aurora Sub, purchased
the remaining approximately 90% equity interest of MedReleaf Australia at a total enterprise value of AUD$50 million subject to customary
adjustments (the "Transaction"). As consideration, Aurora (i) issued the selling shareholders an aggregate of 69,489,941
Aurora Shares (the "Share Consideration"); and (ii) paid the selling shareholders AUD$9.45 million in cash (the "Cash
Consideration" and together with the Share Consideration, the "Consideration"), subject to customary adjustments
post-closing. Approximately 10% of the Consideration will be held in escrow to ensure certain obligations of the selling shareholders.
for Restructuring Transactions
Item 6 Reliance on subsection 7.1(2) of National
Item 7 Omitted Information
Item 8 Executive Officer
Further information regarding the matters described
in this report may be obtained from Ananth Krishnan, Vice President, Strategic Finance, who is knowledgeable about the details of the
Transaction and may be contacted at Ananth.krishnan@auroramj.com.
Item 9 Date of Report